Staar Surgical CoSTAA -6.14%79 EBITDA Margin % is 20.97% as of Mar. 2026, which is 214% above its 10-year median of 6.67. GuruFocus rates STAA with a GF Score™ of 79/100 and a GF Value™ of $31.39 (Fairly Valued). The stock has 7 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Staar Surgical Co ranks worse than 54.66% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Staar Surgical Co's EBITDA for the
three
months ended in Mar. 2026 was $19.6 Mil. Staar Surgical Co's Revenue for the
three
months ended in Mar. 2026 was $93.5 Mil. Therefore, Staar Surgical Co's EBITDA margin for the quarter that ended in Mar. 2026 was 20.97%.
Staar Surgical Co (NAS:STAA) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Staar Surgical Co EBITDA Margin % Related Terms
Staar Surgical Co EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Staar Surgical Co's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STAA vs NNNN, ATRC, PLSE: EBITDA Margin % Comparison
For the Medical Instruments & Supplies subindustry, Staar Surgical Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Staar Surgical Co EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Staar Surgical Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Staar Surgical Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Staar Surgical Co (STAA) has a EBITDA Margin % of 20.97% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Staar Surgical Co and its competitors. This is 214% above median its historical median of 6.67. According to the industry distribution chart, Staar Surgical Co ranks #446 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 54.7%.
Is Staar Surgical Co's EBITDA Margin % too high?
Staar Surgical Co's current EBITDA Margin % of 20.97% is 214% above median its 10-year median of 6.67. The Medical Devices & Instruments industry median EBITDA Margin % is 7.48. Staar Surgical Co's value of 20.97% is 180.5% above this industry median. Based on the distribution chart, Staar Surgical Co ranks #446 out of 816 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Staar Surgical Co has a GF Score™ of 79/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Staar Surgical Co's EBITDA Margin % compare to NNNN and ATRC?
According to the Medical Devices & Instruments industry distribution chart, Staar Surgical Co ranks #446 out of 816 companies for EBITDA Margin %. This places Staar Surgical Co in the lower half of its industry. The industry median EBITDA Margin % is 7.48. Staar Surgical Co's value of 20.97% is 180.5% above this benchmark. While the company's 10-year median is 6.67 vs. the industry median of 7.48, Staar Surgical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.48, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Staar Surgical Co's current EBITDA Margin % of 20.97% is 180.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Staar Surgical Co and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Staar Surgical Co's current EBITDA Margin % is 20.97%, which is 214% above median its own 10-year median of 6.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Staar Surgical Co stock overvalued right now?
Based on GuruFocus' analysis, Staar Surgical Co (STAA) is currently considered Fairly Valued. The stock's GF Value™ is $31.39, compared to a current price of $29.29 — trading 6.7% below its estimated fair value. The current EBITDA Margin % is 20.97%, which is 214% above median its 10-year median of 6.67 and 180.5% above the Medical Devices & Instruments industry median of 7.48. Staar Surgical Co's overall GF Score™ is 79/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Staar Surgical Co (STAA), the current EBITDA Margin % is 20.97% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Staar Surgical Co (STAA) Overvalued in 2026?
Based on GuruFocus' analysis, Staar Surgical Co stock appears to be undervalued.
The current stock price of $29.29 is trading 6.7% below its estimated GF Value™ of $31.39.
GuruFocus considers Staar Surgical Co to be Fairly Valued.
Key valuation signals for STAA:
EBITDA Margin %: 20.97% (214% above median its 10-year median of 6.67)
GF Value™: $31.39 vs. price of $29.29 (6.7% below fair value)
Industry Position: 180.5% above the Medical Devices & Instruments median (#446 of 816)
No single metric tells the full story. See the STAA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.
79GF Score
Get the complete analysis for STAA
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STAA has been successfully added to your 
